Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

157 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Early ischemic change on CT versus diffusion-weighted imaging for patients with stroke receiving intravenous recombinant tissue-type plasminogen activator therapy: stroke acute management with urgent risk-factor assessment and improvement (SAMURAI) rt-PA registry.
Nezu T, Koga M, Nakagawara J, Shiokawa Y, Yamagami H, Furui E, Kimura K, Hasegawa Y, Okada Y, Okuda S, Kario K, Naganuma M, Maeda K, Minematsu K, Toyoda K. Nezu T, et al. Stroke. 2011 Aug;42(8):2196-200. doi: 10.1161/STROKEAHA.111.614404. Epub 2011 Jun 30. Stroke. 2011. PMID: 21719764
Intravenous recombinant tissue plasminogen activator therapy for stroke patients receiving maintenance hemodialysis: the Stroke Acute Management with Urgent Risk-Factor Assessment and Improvement (SAMURAI) rt-PA registry.
Naganuma M, Mori M, Nezu T, Makihara N, Koga M, Okada Y, Minematsu K, Toyoda K; SAMURAI Study Investigators. Naganuma M, et al. Among authors: nezu t. Eur Neurol. 2011;66(1):37-41. doi: 10.1159/000328792. Epub 2011 Jun 28. Eur Neurol. 2011. PMID: 21709420
Intravenous alteplase at 0.6 mg/kg for acute stroke patients with basilar artery occlusion: the stroke acute management with urgent risk factor assessment and improvement (SAMURAI) Recombinant tissue plasminogen activator registry.
Miyagi T, Koga M, Shiokawa Y, Nakagawara J, Hasegawa Y, Furui E, Kimura K, Kario K, Okuda S, Yamagami H, Okada Y, Nezu T, Maeda K, Endo K, Minematsu K, Toyoda K. Miyagi T, et al. Among authors: nezu t. J Stroke Cerebrovasc Dis. 2013 Oct;22(7):1098-106. doi: 10.1016/j.jstrokecerebrovasdis.2012.08.013. Epub 2012 Oct 10. J Stroke Cerebrovasc Dis. 2013. PMID: 23063059
CHADS2 score is associated with 3-month clinical outcomes after intravenous rt-PA therapy in stroke patients with atrial fibrillation: SAMURAI rt-PA Registry.
Koga M, Kimura K, Shibazaki K, Shiokawa Y, Nakagawara J, Furui E, Yamagami H, Okada Y, Hasegawa Y, Kario K, Okuda S, Naganuma M, Nezu T, Maeda K, Minematsu K, Toyoda K. Koga M, et al. Among authors: nezu t. J Neurol Sci. 2011 Jul 15;306(1-2):49-53. doi: 10.1016/j.jns.2011.03.046. Epub 2011 Apr 14. J Neurol Sci. 2011. PMID: 21492878
Association of serum anti-periodontal pathogen antibody with ischemic stroke.
Hosomi N, Aoki S, Matsuo K, Deguchi K, Masugata H, Murao K, Ichihara N, Ohyama H, Dobashi H, Nezu T, Ohtsuki T, Yasuda O, Soejima H, Ogawa H, Izumi Y, Kohno M, Tanaka J, Matsumoto M. Hosomi N, et al. Among authors: nezu t. Cerebrovasc Dis. 2012;34(5-6):385-92. doi: 10.1159/000343659. Epub 2012 Nov 29. Cerebrovasc Dis. 2012. PMID: 23207319
157 results